SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,459.53 308.49
( 0.42%)

Global Indices

Nasdaq

51,732.40 -631.16
(-1.21%)

Dow Jones

7,581.68 -159.71
(-2.06%)

Hang Seng

63,176.05 -1,483.42
(-2.29%)

Nikkei 225

10,722.51 0.44
(0.00%)

Forex

USD-INR

95.22 0.06
(0.06%)

EUR-INR

106.19 0.24
(0.23%)

GBP-INR

127.01 0.44
(0.35%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1170.8077615

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

27.34

61277.06

EPS(TTM)

Face Value()

Div & Yield %

187.45

1.03

Back

Capital Infra Trust reports consolidated net profit of Rs 125.62 crore in the June 2026 quarter

Jul 22,2026

Net profit of Capital Infra Trust reported to Rs 125.62 crore in the quarter ended June 2026 as against net loss of Rs 73.72 crore during the previous quarter ended June 2025. Sales rose 37.41% to Rs 259.29 crore in the quarter ended June 2026 as against Rs 188.70 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	259.29	188.70	37
OPM %	55.96	-42.74	-
PBDT	128.44	-108.29	LP
PBT	128.44	-108.29	LP
NP	125.62	-73.72	LP

74,459.53 308.49 ( 0.42%)

51,732.40 -631.16 (-1.21%)

7,581.68 -159.71 (-2.06%)

63,176.05 -1,483.42 (-2.29%)

10,722.51 0.44 (0.00%)

95.22 0.06 (0.06%)

106.19 0.24 (0.23%)

127.01 0.44 (0.35%)

0.60 0.00 (0.12%)